Common maintenance approaches include staying at the dose where you stabilized (often 1.0 to 1.7 mg), reducing by one dose level from your peak (e.g., from 2.4 mg to 1.7 mg), or finding the minimum dose that prevents weight regain while minimizing side effects
This requires a valid prescription and is subject to compounding regulations that vary by state
We already are having clients positioning themselves for it, says Jesse Dresser, a partner at Frier Levitt
used with permission.) B, Immunofluorescence of biopsy specimen showing the characteristic immunoglobulin A deposits in the papillary dermis
GLP-1 agonists, such as semaglutide and tirzepatide, mimic the natural GLP-1 (glucagon-like peptide-1) hormones your body produces
How to frame PDA use around surgery